Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor

AIDS. 2002 Jan 25;16(2):304-5. doi: 10.1097/00002030-200201250-00029.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / immunology
  • AIDS-Related Opportunistic Infections / virology
  • Adult
  • Alkynes
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Benzoxazines
  • CD4 Lymphocyte Count
  • Cyclopropanes
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Homosexuality, Male
  • Humans
  • Lamivudine / therapeutic use*
  • Male
  • Nucleosides / therapeutic use
  • Oxazines / therapeutic use*
  • RNA, Viral / blood
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / immunology
  • Sarcoma, Kaposi / virology
  • Treatment Outcome
  • Viral Load
  • Zidovudine / therapeutic use*

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Nucleosides
  • Oxazines
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • efavirenz